Detailed molecular analysis of 1p36 in neuroblastoma
Background Several lines of evidence establish that chromosome band 1p36 is frequently deleted in neuroblastoma primary tumors and cell lines, suggesting that a tumor suppressor gene within this region is involved in the development of this tumor. Procedure We analyzed the status of 1p36 in primary...
Saved in:
Published in: | Medical and pediatric oncology Vol. 36; no. 1; pp. 37 - 41 |
---|---|
Main Authors: | , , , , , , , , , , , , , |
Format: | Journal Article |
Language: | English |
Published: |
New York
John Wiley & Sons, Inc
01-01-2001
|
Subjects: | |
Online Access: | Get full text |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Summary: | Background
Several lines of evidence establish that chromosome band 1p36 is frequently deleted in neuroblastoma primary tumors and cell lines, suggesting that a tumor suppressor gene within this region is involved in the development of this tumor.
Procedure
We analyzed the status of 1p36 in primary neuroblastomas and cell lines to define the region of consistent rearrangement.
Results
Loss of heterozygosity (LOH) studies of primary neuroblastomas identified allelic loss in 135 of 503 tumors (27%), with the smallest region of overlap (SRO) defined distal to D1S214 (1p36.3). No homozygous deletions were detected at 120 loci mapping to 1p36.1–p36.3 in a panel of 46 neuroblastoma cell lines. A recently identified patient with neuroblastoma was found to have a constitutional deletion within 1p36.2–p36.3, and this deletion, when combined with the LOH results, defined a smaller SRO of one megabase within 1p36.3. We constructed a comprehensive integrated map of chromosome 1 containing 11,000 markers and large‐insert clones, a high‐resolution radiation hybrid (RH) map of 1p36, and a P1‐artificial chromosome (PAC) contig spanning the SRO, to further characterize the region of interest. Over 768 kb (75%) of the SRO has been sequenced to completion. Further analysis of distal 1p identified 113 transcripts localizing to 1p36, 21 of which were mapped within the SRO.
Conclusion
This analysis will identify suitable positional candidate transcripts for mutational screening and subsequent identification of the 1p36.3 neuroblastoma suppressor gene. Med. Pediatr. Oncol. 36: 37–41, 2001. © 2001 Wiley‐Liss, Inc. |
---|---|
Bibliography: | ArticleID:MPO1010 NIH - No. CA-39771 (GMB) istex:2F917382DB903324838836671F161B5C6C1CD11E ark:/67375/WNG-92JGSZ7Z-8 ObjectType-Article-1 SourceType-Scholarly Journals-1 ObjectType-Feature-2 content type line 23 |
ISSN: | 0098-1532 1096-911X |
DOI: | 10.1002/1096-911X(20010101)36:1<37::AID-MPO1010>3.0.CO;2-L |